Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Predictmedix AI Inc C.PMED

Alternate Symbol(s):  PMEDF

Predictmedix AI Inc. is a life sciences technology company. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. It has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. It is also developing AI-powered products that address detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. It is adding additional modules to this Mobile Wellbeing platform that enable us to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.


CSE:PMED - Post by User

Post by Hiddensecretson Jul 16, 2020 8:49pm
540 Views
Post# 31279034

Projected Revenues : $ 99,000,000 year one (1)

Projected Revenues : $ 99,000,000 year one (1)I expect that Predictmedix will be able to sign 10% of the Fortune 500 companies over the next year. 

That means 50 companies, each with approximately 55,000 employees.

I am assuming $ 3 fee per employee per month.

Revenue will be as follows:

50 companies * 55,000 employees * $ 3 per month * 12 months = $ 99,000,000/year


This goes directly to the bottom line as there is not much cost to PMED.

Given that we are in tech industry and more precisely in software, we will trade at about 7 times to 10 times sales. 

For year 1, calculation would bring us to stock price of $ 7 to $ 10 per share.

Remember that this is recurring, so year 2, we add another 50 Fortune 500 companies.

You get the drift.

HUGE OPPORTUNITY, tremendous GROWTH.

MPO
<< Previous
Bullboard Posts
Next >>